The DOI matches its Crossref record.
Clinical trial of mebendazole, a broad-spectrum anthelminthic.
Open accessAbstract
Eighty-five children aged 5-14 years who were infested with worms were treated with mebendazole 100 mg twice daily for three days. The percentage cure rates were ascaris 100%, trichuris 94%, hookworm 82%, and hymenolepis 39%. The drug was well tolerated and with its broad activity should be very useful in treating those with multiple infestations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The therapeutic effect (40% CR) of mebendazole (200 mg daily for 3 days) against human G. lamblia infection was first reported by Hutchison et al. [278] in 1975.”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [278]
Citations
Cited by
Sorted by citations
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Metadata
- Authors
- Hutchison, J. G., Johnston, N. M., Plevey, M. V., Thangkhiew, I., & Aidney, C.
- Affiliations
- University of Helsinki (FI)
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1975-05-10
- Volume
- 2
- Issue
- 5966
- Pages
- 309-310
- ISSN
- 0007-1447 (ISSN-L)
- 1468-5833
- OpenAlex
- W2049602674
- Cited by
- 37
- References
- 0
- Citations by year
- 2023: 1 · 2021: 1 · 2018: 1
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
- Locations
- BMJ (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Janssen Pharmaceuticals
- Topics
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Life Sciences › Immunology and Microbiology › Parasitology › Helminth infection and control
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Keywords
- mebendazole, anthelmintic treatment, intestinal worm infection, Ascaris lumbricoides, Trichuris trichiura, hookworm, Hymenolepis nana, children, cure rate, drug tolerability
- MeSH terms
- Adolescent, Anthelmintics, Ascariasis, Benzimidazoles, Child, Female, Giardiasis, Helminthiasis, Hookworm Infections, Humans, Hymenolepiasis, Male, Mebendazole, Pregnancy, Taeniasis, Trichuriasis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
